Development of CAPER peptides for the treatment of triple negative breast cancer

Triple negative breast cancer (TNBC) is a heterogeneous disease, which lacks expression of the estrogen receptor (ER), progesterone receptor (PR) and the human epidermal growth factor 2 receptor (HER2). This subtype of breast cancer has the poorest prognosis with limited therapies currently availabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chilewski, Shannon D., Bhosale, Devyani, Dees, Sundee, Hutchinson, Isaac, Trimble, Rachel, Pontiggia, Laura, Mercier, Isabelle, Jasmin, Jean-Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100886/
https://www.ncbi.nlm.nih.gov/pubmed/31931653
http://dx.doi.org/10.1080/15384101.2020.1711579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100886/
https://www.ncbi.nlm.nih.gov/pubmed/31931653
http://dx.doi.org/10.1080/15384101.2020.1711579

Ejemplares similares